CoChat

Actin polymerization controls cilia-mediated signaling

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Primary cilia are polarized organelles that allow detection of extracellular signals such as Hedgehog (Hh). How the cytoskeleton supporting the cilium generates and maintains a structure that finely tunes cellular response remains unclear. Here, we find that regulation of actin polymerization controls primary cilia and Hh signaling. Disrupting actin polymerization, or knockdown of N-WASp/Arp3, increases ciliation frequency, axoneme length, and Hh signaling. Cdc42, a potent actin regulator, recruits both atypical protein pinase C iota/lambda (aPKC) and Missing-in-Metastasis (MIM) to the basal body to maintain actin polymerization and restrict axoneme length. Transcriptome analysis implicates the Src pathway as a major aPKC effector. aPKC promotes whereas MIM antagonizes Src activity to maintain proper levels of primary cilia, actin polymerization, and Hh signaling. Hh pathway activation requires Smoothened-, Gli-, and Gli1-specific activation by aPKC. Surprisingly, longer axonemes can amplify Hh signaling, except when aPKC is disrupted, reinforcing the importance of the Cdc42–aPKC–Gli axis in actin-dependent regulation of primary cilia signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.201703196

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Cytochalasin B induces axoneme length changes to regulate Hh signaling. (A) Immunofluorescence of NIH 3T3 cells treated with or without 10 µM cytochalasin B (CytoB) for the indicated times and stained for Arl13b, γ-tubulin (gTub), and DNA (DAPI). Bar, 5 µm. (B and C) Violin plot of axoneme lengths from confluent NIH 3T3 cells (B) and percentage of cells displaying primary cilia (C) after treatment with 10 µM CytoB for the indicated amounts of time (n = 3 experiments). tx, treatment. (D) Gli1 mRNA levels of confluent NIH 3T3 cells treated with Shh-CM and 10 µM CytoB for the indicated amounts of time (n = 3 experiments). dR, delta reporter signal normalized to passive reference dye. (E and F) Violin plot of axoneme lengths from subconfluent Gli2−/−; Gli3−/− and Smo−/− MEFs (E) and percentage of cells displaying primary cilia (F) after 3-h treatment with 10 µM CytoB (n = 3 experiments). (G) Gli1 mRNA levels of Gli2−/−; Gli3−/− and Smo−/− MEFs treated with or without Shh-CM and/or 3 h of 10 µM CytoB (n = 3 experiments). CM, conditioned media. Error bars represent SEM. Significance was determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Figure 1. Cytochalasin B induces axoneme length changes to regulate Hh signaling. (A) Immunofluorescence of NIH 3T3 cells treated with or without 10 µM cytochalasin B (CytoB) for the indicated times and stained for Arl13b, γ-tubulin (gTub), and DNA (DAPI). Bar, 5 µm. (B and C) Violin plot of axoneme lengths from confluent NIH 3T3 cells (B) and percentage of cells displaying primary cilia (C) after treatment with 10 µM CytoB for the indicated amounts of time (n = 3 experiments). tx, treatment. (D) Gli1 mRNA levels of confluent NIH 3T3 cells treated with Shh-CM and 10 µM CytoB for the indicated amounts of time (n = 3 experiments). dR, delta reporter signal normalized to passive reference dye. (E and F) Violin plot of axoneme lengths from subconfluent Gli2−/−; Gli3−/− and Smo−/− MEFs (E) and percentage of cells displaying primary cilia (F) after 3-h treatment with 10 µM CytoB (n = 3 experiments). (G) Gli1 mRNA levels of Gli2−/−; Gli3−/− and Smo−/− MEFs treated with or without Shh-CM and/or 3 h of 10 µM CytoB (n = 3 experiments). CM, conditioned media. Error bars represent SEM. Significance was determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).CC BY-NC-SA · PubMed Central
Figure 2. Actin nucleators restrict axoneme length and Hh signaling. (A) Immunofluorescence of mDCs stained for Arp3 or N-WASp with acetylated-tubulin (AcTub)–positive primary cilia. Immunoreactivity around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm. (B and C) Percentage of subconfluent mDCs displaying primary cilia (B) and violin plot of axoneme lengths (C) after shRNA knockdown of control (n = 4 experiments), N-WASp (n = 3 experiments), or Arp3 (n = 4 experiments). sh, short hairpin. (D) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments), N-WASp (n = 5 experiments), or Arp3 (n = 3 experiments) and treated with control-conditioned media or Shh-CM. CM, conditioned media; KD, knockdown. dR, delta reporter signal normalized to passive reference dye. (E and F) Violin plot of axoneme lengths from confluent NIH 3T3 cells (E) and percentage of cells displaying primary cilia (F) after treatment with 20 µM CK666 for the indicated amounts of time (n = 3 experiments). tx, treatment. (G) Gli1 mRNA levels of confluent NIH 3T3 cells treated with Shh-CM and 20 µM CK666 for the indicated amounts of time (n = 3 experiments). Error bars represent SEM. Significance determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Figure 2. Actin nucleators restrict axoneme length and Hh signaling. (A) Immunofluorescence of mDCs stained for Arp3 or N-WASp with acetylated-tubulin (AcTub)–positive primary cilia. Immunoreactivity around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm. (B and C) Percentage of subconfluent mDCs displaying primary cilia (B) and violin plot of axoneme lengths (C) after shRNA knockdown of control (n = 4 experiments), N-WASp (n = 3 experiments), or Arp3 (n = 4 experiments). sh, short hairpin. (D) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments), N-WASp (n = 5 experiments), or Arp3 (n = 3 experiments) and treated with control-conditioned media or Shh-CM. CM, conditioned media; KD, knockdown. dR, delta reporter signal normalized to passive reference dye. (E and F) Violin plot of axoneme lengths from confluent NIH 3T3 cells (E) and percentage of cells displaying primary cilia (F) after treatment with 20 µM CK666 for the indicated amounts of time (n = 3 experiments). tx, treatment. (G) Gli1 mRNA levels of confluent NIH 3T3 cells treated with Shh-CM and 20 µM CK666 for the indicated amounts of time (n = 3 experiments). Error bars represent SEM. Significance determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).CC BY-NC-SA · PubMed Central
Figure 3. Cdc42 regulates primary cilia and Hh signaling by recruiting aPKC–Par6a to the basal body. (A) Immunofluorescence of mDCs stained for Toca1 or Cdc42 with acetylated-tubulin (AcTub) – or adenyl cyclase III (ACIII)–positive primary cilia. Immunoreactivity around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm. (B and C) Percentage of subconfluent mDCs displaying primary cilia (B) and violin plot of axoneme lengths (C) after shRNA knockdown of control (n = 4 experiments), Toca1 (n = 3 experiments), or Cdc42 (n = 4 experiments). sh, short hairpin. (D) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments), Toca1 (n = 2 experiments), or Cdc42 (n = 3 experiments) and treated with control-conditioned media or Shh-CM. CM, conditioned media. dR, delta reporter signal normalized to passive reference dye. (E and F) Percentage of subconfluent mDCs displaying primary cilia (E) and violin plot of axoneme lengths (F) after shRNA knockdown of control (n = 4 experiments), aPKC (n = 4 experiments), Par6a (n = 4 experiments), or Par3 (n = 4 experiments). sh, short hairpin. (G) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments) or aPKC (n = 6 experiments) and treated with control-conditioned media or Shh-CM. KD, knockdown. Error bars represent SEM. Significance determined by unpaired two-tailed t test (**, P < 0.01; ***, P < 0.001). (H) Immunofluorescence of control, aPKC, Par6a, Cdc42, or Par3 knockdown mDCs stained for indicated proteins and AcTub/ACIII–positive primary cilia or pericentrin/γ-tubulin (gtub)–positive basal bodies. Immunoreactivity around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm. (I) Western blot of control, Cdc42, or Par3 knockdown mDCs that are probed for polarity proteins and actin.
Figure 3. Cdc42 regulates primary cilia and Hh signaling by recruiting aPKC–Par6a to the basal body. (A) Immunofluorescence of mDCs stained for Toca1 or Cdc42 with acetylated-tubulin (AcTub) – or adenyl cyclase III (ACIII)–positive primary cilia. Immunoreactivity around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm. (B and C) Percentage of subconfluent mDCs displaying primary cilia (B) and violin plot of axoneme lengths (C) after shRNA knockdown of control (n = 4 experiments), Toca1 (n = 3 experiments), or Cdc42 (n = 4 experiments). sh, short hairpin. (D) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments), Toca1 (n = 2 experiments), or Cdc42 (n = 3 experiments) and treated with control-conditioned media or Shh-CM. CM, conditioned media. dR, delta reporter signal normalized to passive reference dye. (E and F) Percentage of subconfluent mDCs displaying primary cilia (E) and violin plot of axoneme lengths (F) after shRNA knockdown of control (n = 4 experiments), aPKC (n = 4 experiments), Par6a (n = 4 experiments), or Par3 (n = 4 experiments). sh, short hairpin. (G) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments) or aPKC (n = 6 experiments) and treated with control-conditioned media or Shh-CM. KD, knockdown. Error bars represent SEM. Significance determined by unpaired two-tailed t test (**, P < 0.01; ***, P < 0.001). (H) Immunofluorescence of control, aPKC, Par6a, Cdc42, or Par3 knockdown mDCs stained for indicated proteins and AcTub/ACIII–positive primary cilia or pericentrin/γ-tubulin (gtub)–positive basal bodies. Immunoreactivity around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm. (I) Western blot of control, Cdc42, or Par3 knockdown mDCs that are probed for polarity proteins and actin.CC BY-NC-SA · PubMed Central
Figure 4. aPKC activity is necessary to regulate primary cilia frequency and axoneme length. (A) Immunofluorescence of control-treated or 10 µM PSI–treated mDCs stained for phosphorylated aPKC (P-aPKC), phosphorylated Gli1 (P-Gli), and primary cilia (AcTub). Immunoreactivity around the basal body is highlighted in the lower right of each panel. tx, treatment. Bars: 10 µm; (inset) 2 µm. (B) Western blot of control or PSI-treated mDCs that are probed for aPKC, P-aPKC, Gli1, P-Gli1, and actin. (C and D) Percentage of subconfluent mDCs with primary cilia upon dose-dependent (C; n = 2 experiments) or temporal addition of 10 µM PSI (D; n = 3 experiments). (E) Violin plot of axoneme length upon temporal addition of 10 µM PSI. (F and G) Percentage of cells displaying primary cilia (F) and violin plot of axoneme lengths (G) from confluent NIH 3T3 cells after treatment with 10 µM PSI for the indicated amounts of time (n = 3 experiments). (H) Gli1 mRNA levels of confluent NIH 3T3 cells treated with Shh-CM and 10 µM PSI for the indicated amounts of time (n = 3 experiments). dR, delta reporter signal normalized to passive reference dye. (I) Pathway analysis of down-regulated transcripts in PSI-treated ASZ001 cells compared with DMSO control. Number of genes in dataset compared with total number of genes displayed as a fraction to the right of each bar. KEA, kinase enrichment analysis; PPI, protein–protein interaction database. Human endogenous complexome, HEC. (J) Heat map of significantly changed transcripts in the Src pathway in PSI-treated ASZ001 cells compared with DMSO control. (K) Quantitative reverse-transcription PCR validation of selected components of the Src pathway in PSI-treated ASZ001 cells compared with DMSO control (n = 3 experiments). Error bars represent SEM. Significance determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Figure 4. aPKC activity is necessary to regulate primary cilia frequency and axoneme length. (A) Immunofluorescence of control-treated or 10 µM PSI–treated mDCs stained for phosphorylated aPKC (P-aPKC), phosphorylated Gli1 (P-Gli), and primary cilia (AcTub). Immunoreactivity around the basal body is highlighted in the lower right of each panel. tx, treatment. Bars: 10 µm; (inset) 2 µm. (B) Western blot of control or PSI-treated mDCs that are probed for aPKC, P-aPKC, Gli1, P-Gli1, and actin. (C and D) Percentage of subconfluent mDCs with primary cilia upon dose-dependent (C; n = 2 experiments) or temporal addition of 10 µM PSI (D; n = 3 experiments). (E) Violin plot of axoneme length upon temporal addition of 10 µM PSI. (F and G) Percentage of cells displaying primary cilia (F) and violin plot of axoneme lengths (G) from confluent NIH 3T3 cells after treatment with 10 µM PSI for the indicated amounts of time (n = 3 experiments). (H) Gli1 mRNA levels of confluent NIH 3T3 cells treated with Shh-CM and 10 µM PSI for the indicated amounts of time (n = 3 experiments). dR, delta reporter signal normalized to passive reference dye. (I) Pathway analysis of down-regulated transcripts in PSI-treated ASZ001 cells compared with DMSO control. Number of genes in dataset compared with total number of genes displayed as a fraction to the right of each bar. KEA, kinase enrichment analysis; PPI, protein–protein interaction database. Human endogenous complexome, HEC. (J) Heat map of significantly changed transcripts in the Src pathway in PSI-treated ASZ001 cells compared with DMSO control. (K) Quantitative reverse-transcription PCR validation of selected components of the Src pathway in PSI-treated ASZ001 cells compared with DMSO control (n = 3 experiments). Error bars represent SEM. Significance determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).CC BY-NC-SA · PubMed Central
Figure 5. aPKC antagonizes MIM downstream of Cdc42. (A and B) Percentage of subconfluent mDCs displaying primary cilia (A) and violin plot of axoneme length (B) after shRNA knockdown (KD) of control (n = 4 experiments), MIM (n = 7 experiments), aPKC and MIM (n = 7 experiments), or Par3 and MIM (n = 3 experiments). (C) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments), MIM (n = 3 experiments), or aPKC and MIM (n = 3 experiments) and treated with control-conditioned media or Shh-CM. CM, conditioned media. dR, delta reporter signal normalized to passive reference dye. (D) Phalloidin staining quantification of subconfluent mDCs after shRNA knockdown of control, aPKC, or MIM (n > 50 cells). Error bars represent SEM. Significance was determined by unpaired two-tailed t test (**, P < 0.01; ***, P < 0.001). (E) Immunofluorescence of control, aPKC, Par6a, Cdc42, or Par3 knockdown mDCs stained for MIM and acetylated-tubulin (AcTub)–positive primary cilia. MIM staining around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm.
Figure 5. aPKC antagonizes MIM downstream of Cdc42. (A and B) Percentage of subconfluent mDCs displaying primary cilia (A) and violin plot of axoneme length (B) after shRNA knockdown (KD) of control (n = 4 experiments), MIM (n = 7 experiments), aPKC and MIM (n = 7 experiments), or Par3 and MIM (n = 3 experiments). (C) Gli1 mRNA levels of confluent mDCs after shRNA knockdown of control (n = 9 experiments), MIM (n = 3 experiments), or aPKC and MIM (n = 3 experiments) and treated with control-conditioned media or Shh-CM. CM, conditioned media. dR, delta reporter signal normalized to passive reference dye. (D) Phalloidin staining quantification of subconfluent mDCs after shRNA knockdown of control, aPKC, or MIM (n > 50 cells). Error bars represent SEM. Significance was determined by unpaired two-tailed t test (**, P < 0.01; ***, P < 0.001). (E) Immunofluorescence of control, aPKC, Par6a, Cdc42, or Par3 knockdown mDCs stained for MIM and acetylated-tubulin (AcTub)–positive primary cilia. MIM staining around the basal body is highlighted in the lower right of each panel. Bars: 10 µm; (inset) 2 µm.CC BY-NC-SA · PubMed Central
Figure 6. aPKC and Src positively regulate each other to promote Gli1 activity. (A) Western blot of control, aPKC, or MIM knockdown mDCs that are probed for MIM, total and activated forms of aPKC and Src, and actin. (B and C) Percentage of subconfluent mDCs displaying primary cilia (B) and violin plot of axoneme length (C) after shRNA knockdown of control (n = 2 experiments) or Src (n = 2 experiments for each short hairpin). (D) Percentage of mDCs with primary cilia upon dose-dependent addition of Src inhibitor I (Srci; n = 2 experiments). (E) Percentage of subconfluent mDCs with primary cilia in control treatment (tx) or subthreshold concentrations of PSI, Srci, or both (n = 3 experiments). (F–H) Percentage of cells displaying primary cilia (F), violin plot of axoneme lengths (G), and phalloidin staining quantification (H; n > 100 cells) from subconfluent Src/Fyn/Yes (SYF)−/− MEFs with or without stable transfection of aPKC and/or Src (n = 3 experiments). (I) Western blot of SYF−/− MEFs with or without addition of Src and probed for total and activated forms of aPKC and total Src. (J) Gli1 mRNA levels of SYF−/− MEFs with or without addition of Src or aPKC (n = 4 experiments). dR, delta reporter signal normalized to passive reference dye. (K) Immunofluorescence of NIH 3T3 cells treated with or without 2.5 µM cytochalasin B (CytoB) for 3 h and stained for the indicated proteins. Bar, 30 µm. (L and M) Quantification (L) and nuclear-to-cytoplasmic ratio (M) of the aPKC-specific phosphorylated-Gli1 immunostain (n > 100 cells). Error bars represent SEM. Significance was determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Figure 6. aPKC and Src positively regulate each other to promote Gli1 activity. (A) Western blot of control, aPKC, or MIM knockdown mDCs that are probed for MIM, total and activated forms of aPKC and Src, and actin. (B and C) Percentage of subconfluent mDCs displaying primary cilia (B) and violin plot of axoneme length (C) after shRNA knockdown of control (n = 2 experiments) or Src (n = 2 experiments for each short hairpin). (D) Percentage of mDCs with primary cilia upon dose-dependent addition of Src inhibitor I (Srci; n = 2 experiments). (E) Percentage of subconfluent mDCs with primary cilia in control treatment (tx) or subthreshold concentrations of PSI, Srci, or both (n = 3 experiments). (F–H) Percentage of cells displaying primary cilia (F), violin plot of axoneme lengths (G), and phalloidin staining quantification (H; n > 100 cells) from subconfluent Src/Fyn/Yes (SYF)−/− MEFs with or without stable transfection of aPKC and/or Src (n = 3 experiments). (I) Western blot of SYF−/− MEFs with or without addition of Src and probed for total and activated forms of aPKC and total Src. (J) Gli1 mRNA levels of SYF−/− MEFs with or without addition of Src or aPKC (n = 4 experiments). dR, delta reporter signal normalized to passive reference dye. (K) Immunofluorescence of NIH 3T3 cells treated with or without 2.5 µM cytochalasin B (CytoB) for 3 h and stained for the indicated proteins. Bar, 30 µm. (L and M) Quantification (L) and nuclear-to-cytoplasmic ratio (M) of the aPKC-specific phosphorylated-Gli1 immunostain (n > 100 cells). Error bars represent SEM. Significance was determined by unpaired two-tailed t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001).CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 82

Metadata

Authors
Drummond, M. L., Li, M., Tarapore, E., Nguyen, T. T. L., Barouni, B. J., Cruz, S., Tan, K. C., Oro, A. E., & Atwood, S. X.
Affiliations
  • University of California, Irvine (US)
  • Department of Dermatology, Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA 4
  • Stanford Medicine (US)
Corresponding author
  • Oro, Anthony E.
  • Atwood, Scott X.
Venue
Journal of Cell Biology
Published
2018-06-26
Volume
217
Issue
9
Pages
3255-3266
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2809813982
Cited by
82
References
46
Citations by year
2026: 3 · 2025: 8 · 2024: 8 · 2023: 11 · 2022: 9 · 2021: 14 · 2020: 16 · 2019: 9 · 2018: 4
FWCI
6.59
Type
journal article
Language
en
Open access
Locations
  • The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • National Science Foundation
  • National Institutes of Health (R00CA176847, R01ARO52785)
  • University California, Irvine
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Keywords
primary cilia, actin polymerization, Hedgehog signaling, Cdc42, atypical protein kinase C, MIM, basal bodies, Smoothened, GLI, ciliation, cytoskeleton
MeSH terms
Zinc Finger Protein GLI1, Actins, Animals, Cell Line, Cilia, Enzyme Activation, Gene Expression Regulation, Microfilament Proteins, Neoplasm Proteins, Protein Kinase C, Signal Transduction, 3T3 Cells, src-Family Kinases, cdc42 GTP-Binding Protein, Wiskott-Aldrich Syndrome Protein, Neuronal, Actin-Related Protein 3, Mice, Hedgehog Proteins, Axoneme, Polymerization, Basal Bodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Actin polymerization controls cilia-mediated signaling. https://app.cochat.ai/papers/10.1083/jcb.201703196
The paper
Drummond, M. L., Li, M., Tarapore, E., Nguyen, T. T. L., Barouni, B. J., Cruz, S., Tan, K. C., Oro, A. E., & Atwood, S. X. (2018). Actin polymerization controls cilia-mediated signaling. Journal of Cell Biology. https://doi.org/10.1083/jcb.201703196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.